← All workflows

Promo Materials Review Policy

Draft FDA Promotional Review Policies in Minutes

12 minutes with CaseMark

Fast lane

We have it from here.

Choose the fast one-off run here, or jump into the workspace when you want saved history, revisions, and a fuller matter workflow.

Run this once here

Best for a quick one-off job. Add your email, upload the files, and we'll run the workflow and send the result to your inbox.

1. Add your email so we know where to send the result.

2. Upload the files you want analyzed.

3. Run the workflow and we'll take it from there.

Use in Workspace

Best for ongoing matters

Save and reopen matters, keep documents together, refine the output, rerun with changes, and export or share polished work product when you're done.

Open in Workspace

Need more context?

Scroll for the workflow details below if you want to review what this run handles, what documents help, and what the output looks like.

If this is part of a live matter, the workspace is the better fit: you can keep your documents together, revisit the result, and keep working without starting from scratch.

Jump to detailsOpen in Workspace

Start here

Run this workflow now

Best for a fast one-off run. Add your email, upload the files, and we'll deliver the result without sending you into the full app.

Workflow

Promo Materials Review Policy

Step 1 · Deliver to

Step 3 · Run this workflow

Workflow

Promo Materials Review Policy

Overview

CaseMark's Promotional Materials Review Policy skill automatically drafts comprehensive internal governance policies for life sciences and pharmaceutical companies operating under FDA oversight. The AI generates a complete, structured policy document covering promotional review committee formation, fair balance requirements, substantiation standards, off-label prohibitions, recordkeeping, training, and auditing frameworks. This enables regulatory and compliance teams to establish robust promotional governance in a fraction of the time required for manual drafting.

Drafting a promotional materials review policy from scratch is a painstaking process that requires deep knowledge of FDA regulations, cross-functional coordination, and meticulous attention to compliance details. Life sciences companies often spend weeks assembling input from regulatory, legal, medical, and marketing teams, risking gaps in coverage that can lead to FDA warning letters, enforcement actions, and reputational damage.

CaseMark automates the creation of comprehensive promotional materials review policies by analyzing your product portfolio, organizational structure, and existing compliance documents against FDA regulatory requirements. The AI produces a complete, professionally structured policy with all critical sections—from committee charters to audit procedures—ready for your team's review and customization.

How it works

  1. 1. Upload your product portfolio, organizational details, and existing compliance documents

  2. 2. AI analyzes your inputs against FDA promotional regulations and industry best practices

  3. 3. Review and customize the generated policy sections, committee structure, and procedures

  4. 4. Export the finalized policy in your preferred format (DOCX, PDF)

What you get

  • Purpose & Scope

  • Promotional Review Committee Structure

  • Submission & Review Procedures

  • Fair Balance Requirements

  • Substantiation Standards

  • Off-Label Prohibitions

  • Recordkeeping Requirements

  • Training Program

  • Monitoring & Auditing Framework

  • Appendices (Forms, Checklists, Regulatory Citations)

What it handles

  • Generates complete promotional review committee structure with roles and qualifications

  • Drafts fair balance and substantiation standards aligned with FDA requirements

  • Creates off-label communication prohibitions and safeguards

  • Produces recordkeeping and audit trail frameworks

  • Includes training program requirements and compliance monitoring procedures

  • Generates appendices with submission forms, checklists, and regulatory citations

Required documents

  • Product Portfolio & Labeling

    Current product list, therapeutic areas, and approved labeling for each product

    .pdf, .docx

  • Organizational Structure

    Details on regulatory affairs, medical affairs, legal, and marketing team structures

    .pdf, .docx

  • Existing Compliance Documents

    Current SOPs, prior FDA correspondence, warning letters, or existing promotional policies

    .pdf, .docx

Supporting documents

  • Distribution Channel Overview

    Details on promotional distribution channels including digital, social media, sales force, and CME involvement

    .pdf, .docx

  • Prior FDA Correspondence

    Warning letters, untitled letters, or advisory communications from FDA related to promotional activities

    .pdf, .docx

Why teams use it

Reduce policy drafting time from weeks to minutes while maintaining regulatory rigor

Ensure comprehensive coverage of all FDA promotional compliance requirements in a single document

Standardize promotional review processes across products, teams, and distribution channels

Create audit-ready documentation with built-in recordkeeping and monitoring frameworks

Questions

What FDA regulations does this policy address?

CaseMark generates policies aligned with the FD&C Act and FDA promotional regulations under 21 CFR Parts 201 and 202. The output covers all major compliance areas including fair balance, substantiation, and off-label prohibitions.

Can I customize the Promotional Review Committee structure?

Absolutely. CaseMark drafts a recommended committee structure with roles, qualifications, and functions based on your organizational inputs. You can fully customize roles, reporting lines, and review workflows before finalizing.

Does this cover digital and social media promotional materials?

Yes. CaseMark's generated policy covers all distribution channels including print, digital, social media, websites, email campaigns, trade shows, mobile apps, and CME materials with promotional elements.

How does this handle off-label communication scenarios?

CaseMark drafts comprehensive off-label prohibition sections with clear boundaries, escalation procedures, and safeguards. The policy addresses common gray areas including medical affairs communications and unsolicited requests.

Can I use this for multiple products across different therapeutic areas?

Yes. CaseMark generates a scalable policy framework that applies across your entire product portfolio. You can upload information for multiple therapeutic areas, and the policy will accommodate product-specific requirements within a unified governance structure.

Is the generated policy ready to implement as-is?

CaseMark produces a comprehensive, professionally structured draft that serves as a strong foundation. We recommend having your regulatory affairs and legal teams review the output to tailor it to your specific organizational needs and risk profile before formal adoption.

Related

510k Premarket Notification

Draft FDA 510(k) Submissions in Minutes, Not Weeks

Adverse Event Reporting Policy

Draft FDA-Compliant Adverse Event Policies in Minutes

Aml Compliance Program

Draft Board-Ready AML Compliance Programs in Minutes